Neurodiagnostics Market: Is 2026 the Year "Liquid...

added blog Health

2026-03-05 11:05:32 -

Neurodiagnostics Market: Is 2026 the Year "Liquid Biopsies" Replace Invasive Procedures for Brain Monitoring

A major breakthrough is defining the Neurodiagnostics Market in 2026: the clinical adoption of "Neurological Liquid Biopsies." For years, monitoring the progression of neurodegenerative diseases required expensive imaging or invasive lumbar punctures, but in 2026, high-sensitivity blood tests are identifying "Neurofilament Light Chain" (NfL) and other biomarkers with hospital-grade accuracy....

0 Comments 0 Shares 313 Views 0 Reviews